Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026)
Camp4 Therapeutics recorded quarterly Non-Current Assets of $3.3 million in Q1 2026, down 12.2% quarter-over-quarter from $3.7 million in Q4 2025, and down 70.63% year-over-year from $11.1 million in Q1 2025.
Camp4 Therapeutics' Non-Current Assets history runs 4 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 70.63% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $25.8 million (down 51.97% YoY), while the FY2025 annual figure was $3.7 million, down 68.86% from the prior year.
- Non-Current Assets came in at $3.3 million for Q1 2026 at Camp4 Therapeutics, down from $3.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $15.9 million in Q3 2024 to a low of $3.3 million in Q1 2026.
- A 4-year average of $10.0 million and a median of $10.6 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets decreased 20.15% in 2024 and tumbled 70.63% in 2026, its largest moves.
- Camp4 Therapeutics' Non-Current Assets stood at $14.9 million in 2023, then fell by 20.15% to $11.9 million in 2024, then plunged by 68.86% to $3.7 million in 2025, then slipped by 12.2% to $3.3 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $3.3 million, $3.7 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | 3.71 Mn |
| Sep 30, 2025 | 8.69 Mn |
| Jun 30, 2025 | 10.19 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 11.92 Mn |
| Sep 30, 2024 | 15.86 Mn |
| Dec 31, 2023 | 14.93 Mn |